Calidi Biotherapeutics Stock (AMEX: CLDI) stock price, news, charts, stock research, profile.
You can purchase shares of Calidi Biotherapeutics (AMEX:CLDI) through any online brokerage.
Other companies in Calidi Biotherapeutics’s space includes: OncoCyte (NASDAQ:OCX), Intensity Therapeutics (NASDAQ:INTS), PepGen (NASDAQ:PEPG), Barinthus Biotherapeutics (NASDAQ:BRNS) and Precision BioSciences (NASDAQ:DTIL).
Calidi Biotherapeutics has a consensus price target of $1.67.
The stock price for Calidi Biotherapeutics (AMEX: CLDI) is $1.3792 last updated February 14, 2025 at 7:06 PM EST.
There are no upcoming dividends for Calidi Biotherapeutics.
Calidi Biotherapeutics’s Q1 earnings are confirmed for Tuesday, May 13, 2025.
There is no upcoming split for Calidi Biotherapeutics.
Calidi Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.